Contigen

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2014
02419932014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVES To determine whether Zuidex using a non-cystoscopy mid-urethral injection technique produces as good a result (i.e… (More)
Is this relevant?
2009
2009
PURPOSE In a pivotal trial we evaluated the effectiveness and safety of Macroplastique(R) as minimally invasive endoscopic… (More)
Is this relevant?
2007
2007
OBJECTIVES To evaluate the safety and effectiveness of soft-tissue augmentation of the urethral sphincter with calcium… (More)
Is this relevant?
2004
2004
PURPOSE The durability of Durasphere (Carbon Medical Technologies, Saint Paul, Minnesota), used to treat stress urinary… (More)
Is this relevant?
2001
2001
Intrinsic sphincter deficiency (ISD) is frequently treated with collagen bulking at the bladder neck. The standard material used… (More)
Is this relevant?
1998
1998
Five elastic protein-based polymers, designed as variations of polymer I, (GVGVP)251, elicited different responses when injected… (More)
Is this relevant?
1998
1998
OBJECTIVES Post-radical prostatectomy stress incontinence occurs in up to 20% of patients. Postprostatectomy incontinence is… (More)
Is this relevant?
1995
1995
Stress incontinence affects primarily women, and a common cause is intrinsic sphincter deficiency (ISD). Traditionally, patients… (More)
Is this relevant?
1995
1995
OBJECTIVE To evaluate the effectiveness of periurethral collagen (Contigen) implantation as a treatment for stress incontinence… (More)
Is this relevant?
1995
1995
This was an open trial to evaluate the efficacy and safety of Contigen Bard Collagen Implant for the treatment of urinary… (More)
Is this relevant?